Clinical Trials Logo

Excision Margin clinical trials

View clinical trials related to Excision Margin.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04918381 Completed - Clinical trials for BCC - Basal Cell Carcinoma

CellFX Treat & Resect Low-Risk BCC Feasibility Study

Start date: June 2, 2021
Phase: N/A
Study type: Interventional

This prospective, multicenter, study is designed to evaluate the safety and effectiveness of the CellFX System in adults subjects with low-risk basal cell carcinoma (superficial and nodular) for complete histological clearance of the target lesion followed by surgical tumor excision 60 days post-treatment.